Cardinal Health Signals Normalising Growth as Specialty and At-Home Care Investments Expand

Cardinal Health is seeing growth normalise after a period of exceptional expansion, as the healthcare distributor deepens investment in specialty pharmaceuticals and at-home care services. The shift points to a broader recalibration across the healthcare supply chain, where companies are balancing post-pandemic demand with longer-term structural bets.

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.